Jennings Strouss is proud to partner with ASU Technopolis to present the 5th Annual Commercializing Life Sciences Forum, The Art and Science of Valuing a Bioscience Company. This exciting event will take place on Tuesday, September 1, 2009, at ASU SkySong. The Forum is an annual conference designed to educate and connect life sciences entrepreneurs, investors, and researchers throughout the Southwest.

  • Session 1: Early Stage Valuation

The issues and uncertainties in determining valuation of early stage technology and intellectual property as it transfers from the lab to early stage bioscience companies. Panelists for this session include:

Ron King, PhD, MBA
President, Catapult Bio

Ron Epperson, CLP
President, Intellectual Energy, LLC

Frank X. Curci, Esq
Member/Partner, Jennings Strouss & Salmon

  • Session 2: Company Valuation When Attracting Investment

Issues surrounding the funding of an existing company, e.g., maintaining the founder's stake, down rounds, how to avoid setting a valuation that will make it harder to attract additional capital later. Panelists for this session include:

Rick Gibson
Managing Director, HOTventures

Rick Kovach
Odyssey Capital Group

  • Session 3: Valuation in an M&A Environment

How a company is valued when it is being considered for a merger/acquisition. Panelists for this session include:

Brian C. Jones
Director & Financial Reporting Practice Leader, Technology & Life Sciences
Ringel Kotzin Valuation Services

Blount Swain
Chief Financial Officer
PRN Medical Services

Richard Lieberman, Esq
Member/Partner, Jennings Strouss & Salmon

  • Luncheon with Keynote Speaker Jock Holliman of Valley Ventures

The Fifth Annual Commercializing Life Sciences Forum (CLSF) is presented by ASU Technopolis and Jennings, Strouss & Salmon, and sponsored by Arizona BioIndustry Association, Arizona Department of Commerce, Arizona Technology Enterprises (AzTE), Enable Ventures, Mayo Clinic, Scottsdale IDA, and numerous statewide life science and economic development organizations.

Contact Information

Katie Bien